The largest database of trusted experimental protocols

Ml 9000

Manufactured by Fukuda Denshi
Sourced in Japan

The ML-9000 is a multi-parameter patient monitoring device designed for use in clinical settings. It is capable of measuring and displaying various vital signs, including heart rate, blood pressure, oxygen saturation, and respiratory rate. The ML-9000 is intended to provide healthcare professionals with real-time patient data to support clinical decision-making.

Automatically generated - may contain errors

5 protocols using ml 9000

1

Cardiopulmonary Exercise Testing Equipment

Check if the same lab product or an alternative is used in the 5 most similar protocols
The breath-by-breath gas analyzers used in this study were the CPEX-1 system manufactured by Inter Reha Co. Ltd. (Tokyo, Japan) and the AE-300S manufactured by Minato Medical Science Co. Ltd. (Osaka, Japan). All analyzers were carefully calibrated before the start of this project. Cycle ergometers used in this study were the SE-8, a servomotor-controlled model by Mitsubishi Electric Engineering Co. Ltd. (Nagoya, Japan) and the Corival 400, an electromagnetically braked cycle ergometer (Lode BV, Groningen, The Netherlands). The stress systems used were the ML-4500, ML-6500, and ML-9000 manufactured by Fukuda Denshi Co. Ltd. (Tokyo, Japan). Each of these models can monitor 12-lead ECGs simultaneously while also controlling a cycle ergometer and automatic-cuff blood pressure manometer (FB-300; Fukuda Denshi Co. Ltd. or STBP-780; Nippon Colin Co. Ltd., Komaki, Japan, or Tango; SunTech Medical, Inc., Morrisville, NC, USA).
+ Open protocol
+ Expand
2

Symptom-Limited Cardiopulmonary Exercise Testing

Check if the same lab product or an alternative is used in the 5 most similar protocols
Symptom-limited CPET was performed on an electromagnetically braked upright cycle ergometer (Corival, Load, Holland) with a metabolic gas analyzer (AE-300S; Minato Medical Science, Osaka, Japan). After 4 min of rest on the cycle ergometer, exercise commenced at 20 watt for a 4 min-warm up; then, the work rate was increased by 1 watt every 6 s. During CPET, blood pressure was measured by an automatic, indirect cuff manometer (FB-300; Fukuda Denshi, Tokyo, Japan) every min. HR and electrocardiography (ECG) were monitored using an exercise electrocardiogram (ML-9000; Fukuda Denshi, Tokyo, Japan). The criteria for discontinuation of CPET were (i) if pedal rotations were delayed; (ii) if the patient reached maximum symptom-limited performance determined by a Borg score of ≥17; (iii) when 85% of age-predicated maximal HR was achieved; or (iv) if there was evidence of ST-T changes in ECG or if any cardiac event, such as arrhythmia or chest pain, occurred. Expired gases were continuously measured in all subjects on a breath-by-breath basis. The anaerobic threshold (AT) was determined by gas-exchange criteria as the point of nonlinear increase in ventilation equivalents for oxygen.
+ Open protocol
+ Expand
3

Symptom-limited CPET for Exercise Physiology

Check if the same lab product or an alternative is used in the 5 most similar protocols
Symptom-limited CPET was performed on an electromagnetically braked upright cycle ergometer (Corival, Load, Holland) with a metabolic gas analyzer (AE-300S, Minato Medical Science, Osaka, Japan). After 4 min of rest on the cycle ergometer, exercise was commenced at 20 W for a 4-min warm-up, and then the work rate was increased by 1-W every 6 s. During CPET, blood pressure was measured by an automatic indirect cuff manometer (FB-300, Fukuda Denshi, Tokyo, Japan) every min. HR and electrocardiography (ECG) were monitored using an exercise electrocardiogram (ML-9000, Fukuda Denshi, Tokyo, Japan) [15] (link). The criteria for discontinuation of CPET were (i) if pedal rotations were delayed, (ii) if the patient reached maximum symptom-limited performance determined by a Borg score of ≥ 17, (iii) when 85% of age-predicted maximal HR (APMHR) was achieved, (iv) if there was evidence of ST-T changes in ECG, or if any cardiac event such as arrhythmia or chest pain occurred. Expired gases were measured continuously in all subjects on a breath-by-breath basis. The anaerobic threshold (AT) was determined by gas exchange criteria as the point of nonlinear increase in ventilation equivalents for oxygen. The mean VO2 and HR at warm-up (Wu; 3–4 min after exercise commenced), at AT, at the respiratory compensation point (Rc), and at the exercise peak (Pk) were all measured and recorded.
+ Open protocol
+ Expand
4

Comprehensive Cardiac Assessment Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
All patients underwent a blood test, TTE, and maximal cardiopulmonary exercise testing. Standard 2D Doppler echocardiography (Vivid 7, GE Medical Ultrasound, Horten, Norway or Artida, Toshiba Medical Systems, Tochigi, Japan) was performed for all patients by registered medical sonographers certified by the Japan Society of Ultrasonics in Medicine who were not involved in patient care. LVEF, transmitral early (E) and late (A) diastolic inflow velocities, and early diastolic mitral annular velocity (E′) were assessed in an apical four‐chamber view. Maximal symptom‐limited cardiopulmonary exercise was performed using a cycle ergometer (StrengthErgo240, Mitsubishi Electric Engineering Company, Ltd.) with a ramp protocol with increments of 1 W per 6 s until exhaustion. The stress system was the ML‐9000 (Fukuda Denshi Co. Ltd.). The expired breath‐by‐breath gas exchange measurements were recorded throughout the test (CPEX‐1, Inter Reha Co. Ltd.) and converted into time‐series data every 3 s.
+ Open protocol
+ Expand
5

Cardiopulmonary Exercise Test Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
The anaerobic threshold (AT) and peak V ˙O2 were evaluated using symptom-limited CPX on an upright cycle ergometer (StrengthErgo8, Mitsubishi Electric Engineering, Tokyo, Japan) with an ECG machine (ML-9000, Fukuda Denshi, Ltd., Tokyo, Japan). CPX was performed 2-4 h after a light meal. The tests began as per recommendations by Buchfuhrer et al 11 with 3 min of rest and a 3-min warmup period at 0 W, followed by a continuous increase in the work rate (WR) by 1 W/6 s until exhaustion. The criteria for halting exercise testing in this study are outlined in the American College of Sports Medicine guidelines. 12 The increases in WR were based on the ability of patients to perform the exercises in a period between 8 and 15 min. 11 We measured V ˙O2, V ˙CO2, and V ˙E on a breath-by-breath basis using a gas analyzer (MINATO 300S, Minato Science Co., Ltd., Osaka, Japan). Peak V ˙O2 was determined at the highest WR during exercise. The AT was measured by V-slope method. 13 The respiratory compensation point (RCP) was recorded when an increase in the V ˙E/V ˙CO2 and decrease in PETCO2 occurred simultaneously. 14, 15 The predicted peak V ˙O2 (% peak V ˙O2) and AT (% AT) were based on a normal Japanese population. 16
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!